BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6391887)

  • 1. [Advanced prostatic cancer: therapeutic modalities].
    Faul P; Altwein JE
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1975-80. PubMed ID: 6391887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of hormonal therapy in prostate cancer].
    Altwein JE
    Helv Chir Acta; 1981 Aug; 48(3-4):391-5. PubMed ID: 7287476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of prostatic cancer.
    Schmidt JD
    Urol Clin North Am; 1975 Feb; 2(1):185-96. PubMed ID: 1093059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
    Servadio C
    Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
    Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
    Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostatic carcinoma].
    Klosterhalfen H
    Med Klin; 1977 Mar; 72(10):376-89. PubMed ID: 320437
    [No Abstract]   [Full Text] [Related]  

  • 10. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of prostatic cancer with cyproterone acetate].
    Maier U
    Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU Group.
    de Voogt HJ; Suciu S; Sylvester R; Pavone-Macaluso M; Smith PH; de Pauw M
    Prog Clin Biol Res; 1990; 357():69-72. PubMed ID: 2217479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U
    Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 16. New agents for prostatic carcinoma.
    Mittelman A
    Urology; 1981 Apr; 17(4 Suppl):45-7. PubMed ID: 7193940
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer.
    Santen RJ; English H; Rohner T; Drago J; Lipton A; Harvey H; Simmonds M; Boucher A; Glode LM; Wettlaufer J
    Prog Clin Biol Res; 1985; 185A():359-71. PubMed ID: 4034580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advanced prostate cancer--a therapeutic dilemma?].
    Rübben H; Altwein JE
    Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.